Monod Bio Launches World’s First Fully De Novo Protein Product: Luciferase LuxSit™ Pro for Life Sciences Research and Diagnostics

Posted on by

– LuxSit™ Pro is the first fully de novo protein to enter the commercial market SEATTLE, July 15, 2024 /PRNewswire/ — Monod Bio, a life sciences company using AI to generate new proteins for the research use only (RUO) and in vitro diagnostics (IVD) markets, announced today the launch of…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.